Radiology Today Magazine



Avanca Medical Devices, Inc. Announces Issue Notification for the Reciprocating Procedure Syringe in China and IsraelJune 27, 2011Albuquerque, NM. (June 27, 2011) – Avanca Medical Devices, Inc today announced that the U.S. Patent Office has issued a “Issue Notification Patent for the Reciprocating Procedure Syringes” in China? ZL 2006 8 0008982.2 and IN Israel 00045-05-8 for Avanca’s Reciprocating Procedure Device (RPD?). As a result, Avanca expects that several Internationals patents will be issued relating to this technology in the coming months. The RPD? was developed at the Unversity of New Mexico “UNM” and Avanca Medical Devices, Inc. has an exclusive agreement with the University of New Mexico Science and Technology to license and? commercialize this revolutionary aspiration syringe technology.? The inventors of the RPD?, Dr’s. Wilmer L. Sibbitt JR., Albuquerque, NM, and Randy R. Sibbitt, Helena, MT."The granting of this patent recognizes the unique qualities of Avanca’s RPD?, and we believe the allowance of these patents will add to and strengthen the patent position for various aspiration procedure technologies. The patented technology can be applied to a variety of procedures.?? The RPD? Device enables 1-handed aspiration, freeing up the second hand to palpate anatomic landmarks and facilitate effusion removal.? The Avanca RPD? is used to inject fluids into, or withdraw fluids from, the body, while reducing the risk of injuries and the potential for syringe reuse.? Clinical evidence demonstrates safety, efficacy, improved outcomes and cost effectiveness.? Rheumatologists, Radiologists, Orthopedic Surgeons, and other medical specialties use a syringe and needle to aspirate body fluids, inject medications, and provide vacuum to obtain tissue biopsies.? The unique qualities of the Avanca RPD? have demonstrated that the conventional syringe, especially when transitioning from injection to aspiration, is difficult to precisely control, causing both unintentional forward penetration and unintentional retraction, resulting in erratic needle control and increased pain.? Poor control of the syringe and needle can result in a prolonged procedure time, increased patient pain, a failed procedure, unintended perforation of a blood vessel or other organ, poor sample yield, and delayed diagnosis.Dr. Wilmer Sibbitt, Jr., a physician at UNM’s Health Sciences Center (HSC), commented:? “With any new device, outcome trials to show a benefit to the patient are always necessary.? Outcome trials with the RPD? have demonstrated greater patient safety, much less procedural pain, and better outcomes in syringe procedures, including biopsy and injections fo medications for corticosteroids, hyaluronate, local anesthetics, cosmetic agents and neuromuscular drugs.? New studies combining the RPD? with ultrasound guidance are ongoing and have great promise to improve the safety and outcomes of medical procedures in all fields of procedural medicine.” About Avanca Medical Devices, Inc.Avanca Medical Devices , established in 2004, is a research and development company that is dedicated to innovative design, development and commercialization of “improved” medical devices and consumables that proved increased functionality, safety, patient comfort, and health care professionals in life and physical sciences.? Avanca maximizes the value of intellectual assets for the benefit of its customers, clients and shareholders. Direct inquiries to:Jackie S. AragonGeneral ManagerTel: 505.385.3651Email: Jackie.Aragon@ ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download